A single-arm observational study to characterize the demographic, clinical features and outcomes of a Brazilian cohort of patients with lung cancer. - LUSIP

Study identifier:D133FR00225

ClinicalTrials.gov identifier:NCT07279948

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

A single-arm observational study to characterize the demographic, clinical features and outcomes of a Brazilian cohort of patients with lung cancer.

Medical condition

lung cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

477

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 30 May 2026
Estimated Primary Completion Date: 31 Jan 2027
Estimated Study Completion Date: 31 Jan 2027

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Mar 2026 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria